Bioregenx (BRGX) Gains from Investment Securities (2024)
Bioregenx's (BRGX) quarterly Gains from Investment Securities came in at $19351.0 in Q1 2024.
Bioregenx (BRGX) Gains from Investment Securities (2024) Analysis & Trends
Bioregenx's Gains from Investment Securities history runs 1 years deep, the most recent figure standing at $19351.0 for Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Veeva Systems | 31.81 Bn | 24.49 Bn | 662.02 Mn |
| 2 | BrightSpring Health Services | 14.76 Bn | 13.86 Bn | 482.22 Mn |
| 3 | Healthequity | 8.36 Bn | 8.10 Bn | 256.31 Mn |
| 4 | Hinge Health | 5.91 Bn | 5.60 Bn | 154.23 Mn |
| 5 | 10x Genomics | 5.89 Bn | 5.35 Bn | 106.18 Mn |
| 6 | MiniMed | 4.45 Bn | 4.16 Bn | 480.00 Mn |
| 7 | Waystar Holding | 4.41 Bn | 4.35 Bn | 216.84 Mn |
| 8 | Doximity | 3.93 Bn | 3.18 Bn | 125.97 Mn |
| 9 | Privia Health | 3.10 Bn | 2.68 Bn | - |
| 10 | Bioregenx | 9.69 Mn | 9.65 Mn | 348,288.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 19,351.00 |
| Mar 31, 2024 | 19,351.00 |